Glaxosmithkline Pharmaceuticals Cash Flow Annual

Trade
BSE: 500660 | NSE: GLAXO | ISIN: INE159A01016 | Sector: Biotechnology & Drugs
2,345.90 -69.30 (-2.87%)Updated : 25 Nov 2024
Fiscal Period2024202320222021
Period End DateMar 24Mar 23Mar 22Mar 21
Net Income/ Starting Line 959.80837.37767.47723.10
Depreciation/ Depletion 69.6865.7768.1979.28
Non- Cash Items -254.26-108.46-24.27-123.25
Changesin Working Capital -193.22-310.45-0.64-101.20
Cashfrom Operating Activities 582.00484.23810.75577.93
Capital Expenditures -31.22-44.04-34.64-44.23
Other Investing Cash Flow Items Total 39.94851.89-370.87462.82
Cashfrom Investing Activities 8.72807.85-405.51418.59
Financing Cash Flow Items -1.79-0.96-1.99-3.53
Total Cash Dividends Paid -541.57-1,525.50-506.64-677.62
Issuance( Retirement)of Debt Net -18.13-16.87-15.62-14.98
Cashfrom Financing Activities -561.49-1,543.32-524.24-696.14
Net Changein Cash 29.23-251.25-119.00300.38
Cash Interest Paid 1.791.401.993.53
Cash Taxes Paid 254.23264.71120.51146.96
*All figures in crores except per share values
Recommended For You
Trending Stocks
3,753.25+148.70(4.13%)
1,784.60+38.65(2.21%)
1,733.95-13.75 (-0.79%)
2,460.60-18.40 (-0.74%)
HomeMarketsPremiumInstant LoanMint Shorts